nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Toremifene—ESR1—uterine cancer	0.00495	0.274	CrCbGaD
Doxylamine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00402	0.0041	CcSEcCtD
Doxylamine—Anaphylactic shock—Progesterone—uterine cancer	0.00402	0.00409	CcSEcCtD
Doxylamine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00401	0.00408	CcSEcCtD
Doxylamine—Hepatitis—Dactinomycin—uterine cancer	0.004	0.00407	CcSEcCtD
Doxylamine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00394	0.00402	CcSEcCtD
Doxylamine—Nervous system disorder—Progesterone—uterine cancer	0.00394	0.00401	CcSEcCtD
Doxylamine—Tachycardia—Progesterone—uterine cancer	0.00392	0.00399	CcSEcCtD
Doxylamine—Hyperhidrosis—Progesterone—uterine cancer	0.00389	0.00396	CcSEcCtD
Doxylamine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00387	0.00394	CcSEcCtD
Doxylamine—Anorexia—Progesterone—uterine cancer	0.00383	0.0039	CcSEcCtD
Doxylamine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.00386	CcSEcCtD
Doxylamine—Erythema multiforme—Dactinomycin—uterine cancer	0.00378	0.00385	CcSEcCtD
Doxylamine—Cramp muscle—Etoposide—uterine cancer	0.00377	0.00384	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00377	0.00384	CcSEcCtD
Doxylamine—Hypotension—Progesterone—uterine cancer	0.00376	0.00382	CcSEcCtD
Doxylamine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00375	0.00382	CcSEcCtD
Doxylamine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00378	CcSEcCtD
Doxylamine—Flushing—Dactinomycin—uterine cancer	0.00371	0.00378	CcSEcCtD
Doxylamine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00367	0.00374	CcSEcCtD
Doxylamine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00364	0.00371	CcSEcCtD
Doxylamine—Insomnia—Progesterone—uterine cancer	0.00364	0.0037	CcSEcCtD
Doxylamine—Levomethadyl Acetate—CYP19A1—uterine cancer	0.00363	0.201	CrCbGaD
Doxylamine—Dyspnoea—Progesterone—uterine cancer	0.00358	0.00365	CcSEcCtD
Doxylamine—Bone disorder—Epirubicin—uterine cancer	0.00358	0.00364	CcSEcCtD
Doxylamine—Somnolence—Progesterone—uterine cancer	0.00357	0.00364	CcSEcCtD
Doxylamine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00364	CcSEcCtD
Doxylamine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00363	CcSEcCtD
Doxylamine—Bronchospasm—Etoposide—uterine cancer	0.00356	0.00362	CcSEcCtD
Doxylamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.00362	CcSEcCtD
Doxylamine—Sweating increased—Etoposide—uterine cancer	0.00352	0.00359	CcSEcCtD
Doxylamine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00352	0.00359	CcSEcCtD
Doxylamine—Lacrimation increased—Epirubicin—uterine cancer	0.00351	0.00357	CcSEcCtD
Doxylamine—Decreased appetite—Progesterone—uterine cancer	0.00349	0.00356	CcSEcCtD
Doxylamine—Erythema—Dactinomycin—uterine cancer	0.00348	0.00354	CcSEcCtD
Doxylamine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00347	0.00354	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00347	0.00353	CcSEcCtD
Doxylamine—Fatigue—Progesterone—uterine cancer	0.00347	0.00353	CcSEcCtD
Doxylamine—Constipation—Progesterone—uterine cancer	0.00344	0.0035	CcSEcCtD
Doxylamine—Pancytopenia—Etoposide—uterine cancer	0.00343	0.0035	CcSEcCtD
Doxylamine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0034	0.00347	CcSEcCtD
Doxylamine—Feeling abnormal—Progesterone—uterine cancer	0.00331	0.00337	CcSEcCtD
Doxylamine—Bone disorder—Doxorubicin—uterine cancer	0.00331	0.00337	CcSEcCtD
Doxylamine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.00335	CcSEcCtD
Doxylamine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00325	0.00331	CcSEcCtD
Doxylamine—Lacrimation increased—Doxorubicin—uterine cancer	0.00324	0.0033	CcSEcCtD
Doxylamine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00324	0.0033	CcSEcCtD
Doxylamine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00323	0.00329	CcSEcCtD
Doxylamine—Tamoxifen—ESR2—uterine cancer	0.00321	0.178	CrCbGaD
Doxylamine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.0032	0.00325	CcSEcCtD
Doxylamine—Urticaria—Progesterone—uterine cancer	0.00319	0.00325	CcSEcCtD
Doxylamine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00317	0.00322	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.0032	CcSEcCtD
Doxylamine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.0032	CcSEcCtD
Doxylamine—Malaise—Dactinomycin—uterine cancer	0.00314	0.0032	CcSEcCtD
Doxylamine—Leukopenia—Dactinomycin—uterine cancer	0.00312	0.00317	CcSEcCtD
Doxylamine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.00317	CcSEcCtD
Doxylamine—Agranulocytosis—Etoposide—uterine cancer	0.00301	0.00306	CcSEcCtD
Doxylamine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.003	0.00306	CcSEcCtD
Doxylamine—Hypersensitivity—Progesterone—uterine cancer	0.00296	0.00302	CcSEcCtD
Doxylamine—Discomfort—Dactinomycin—uterine cancer	0.00293	0.00298	CcSEcCtD
Doxylamine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00289	0.00295	CcSEcCtD
Doxylamine—Asthenia—Progesterone—uterine cancer	0.00288	0.00294	CcSEcCtD
Doxylamine—Urinary tract disorder—Etoposide—uterine cancer	0.00286	0.00291	CcSEcCtD
Doxylamine—Pruritus—Progesterone—uterine cancer	0.00284	0.0029	CcSEcCtD
Doxylamine—Urethral disorder—Etoposide—uterine cancer	0.00284	0.00289	CcSEcCtD
Doxylamine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00278	0.00283	CcSEcCtD
Doxylamine—Diarrhoea—Progesterone—uterine cancer	0.00275	0.0028	CcSEcCtD
Doxylamine—Erythema multiforme—Etoposide—uterine cancer	0.00274	0.00279	CcSEcCtD
Doxylamine—Anorexia—Dactinomycin—uterine cancer	0.00271	0.00276	CcSEcCtD
Doxylamine—Eye disorder—Etoposide—uterine cancer	0.0027	0.00275	CcSEcCtD
Doxylamine—Flushing—Etoposide—uterine cancer	0.00269	0.00274	CcSEcCtD
Doxylamine—Cardiac disorder—Etoposide—uterine cancer	0.00269	0.00274	CcSEcCtD
Doxylamine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.00273	CcSEcCtD
Doxylamine—Dizziness—Progesterone—uterine cancer	0.00266	0.00271	CcSEcCtD
Doxylamine—Immune system disorder—Etoposide—uterine cancer	0.00261	0.00266	CcSEcCtD
Doxylamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00261	0.00266	CcSEcCtD
Doxylamine—Mediastinal disorder—Etoposide—uterine cancer	0.00261	0.00266	CcSEcCtD
Doxylamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00262	CcSEcCtD
Doxylamine—Vomiting—Progesterone—uterine cancer	0.00256	0.0026	CcSEcCtD
Doxylamine—Rash—Progesterone—uterine cancer	0.00253	0.00258	CcSEcCtD
Doxylamine—Dermatitis—Progesterone—uterine cancer	0.00253	0.00258	CcSEcCtD
Doxylamine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00254	CcSEcCtD
Doxylamine—Decreased appetite—Dactinomycin—uterine cancer	0.00247	0.00251	CcSEcCtD
Doxylamine—Fatigue—Dactinomycin—uterine cancer	0.00245	0.00249	CcSEcCtD
Doxylamine—Muscle spasms—Etoposide—uterine cancer	0.00242	0.00247	CcSEcCtD
Doxylamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00245	CcSEcCtD
Doxylamine—Nausea—Progesterone—uterine cancer	0.00239	0.00243	CcSEcCtD
Doxylamine—Diplopia—Epirubicin—uterine cancer	0.00234	0.00239	CcSEcCtD
Doxylamine—Feeling abnormal—Dactinomycin—uterine cancer	0.00234	0.00238	CcSEcCtD
Doxylamine—Ill-defined disorder—Etoposide—uterine cancer	0.00234	0.00238	CcSEcCtD
Doxylamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00236	CcSEcCtD
Doxylamine—Affect lability—Epirubicin—uterine cancer	0.00231	0.00235	CcSEcCtD
Doxylamine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00234	CcSEcCtD
Doxylamine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00234	CcSEcCtD
Doxylamine—Malaise—Etoposide—uterine cancer	0.00227	0.00231	CcSEcCtD
Doxylamine—Vertigo—Etoposide—uterine cancer	0.00226	0.00231	CcSEcCtD
Doxylamine—Leukopenia—Etoposide—uterine cancer	0.00226	0.0023	CcSEcCtD
Doxylamine—Mood swings—Epirubicin—uterine cancer	0.00222	0.00226	CcSEcCtD
Doxylamine—Convulsion—Etoposide—uterine cancer	0.00218	0.00222	CcSEcCtD
Doxylamine—Dehydration—Epirubicin—uterine cancer	0.00218	0.00222	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—uterine cancer	0.00217	0.00221	CcSEcCtD
Doxylamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.0022	CcSEcCtD
Doxylamine—Tamoxifen—CYP19A1—uterine cancer	0.00215	0.119	CrCbGaD
Doxylamine—Orthostatic hypotension—Epirubicin—uterine cancer	0.00214	0.00218	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—uterine cancer	0.00214	0.00217	CcSEcCtD
Doxylamine—Methadone—CYP19A1—uterine cancer	0.00213	0.118	CrCbGaD
Doxylamine—Discomfort—Etoposide—uterine cancer	0.00212	0.00216	CcSEcCtD
Doxylamine—Breast disorder—Epirubicin—uterine cancer	0.00212	0.00216	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00211	0.00215	CcSEcCtD
Doxylamine—Nasopharyngitis—Epirubicin—uterine cancer	0.0021	0.00214	CcSEcCtD
Doxylamine—Hypersensitivity—Dactinomycin—uterine cancer	0.00209	0.00213	CcSEcCtD
Doxylamine—Confusional state—Etoposide—uterine cancer	0.00207	0.00211	CcSEcCtD
Doxylamine—Anaphylactic shock—Etoposide—uterine cancer	0.00206	0.00209	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—uterine cancer	0.00206	0.00209	CcSEcCtD
Doxylamine—Asthenia—Dactinomycin—uterine cancer	0.00204	0.00208	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—uterine cancer	0.00202	0.00205	CcSEcCtD
Doxylamine—Thrombocytopenia—Etoposide—uterine cancer	0.00201	0.00205	CcSEcCtD
Doxylamine—Tachycardia—Etoposide—uterine cancer	0.00201	0.00204	CcSEcCtD
Doxylamine—Hyperhidrosis—Etoposide—uterine cancer	0.00199	0.00202	CcSEcCtD
Doxylamine—Pancreatitis—Epirubicin—uterine cancer	0.00199	0.00202	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00198	0.00202	CcSEcCtD
Doxylamine—Tamoxifen—ESR1—uterine cancer	0.00198	0.11	CrCbGaD
Doxylamine—Breast disorder—Doxorubicin—uterine cancer	0.00196	0.002	CcSEcCtD
Doxylamine—Anorexia—Etoposide—uterine cancer	0.00196	0.002	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00195	0.00199	CcSEcCtD
Doxylamine—Diarrhoea—Dactinomycin—uterine cancer	0.00194	0.00198	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00194	0.00198	CcSEcCtD
Doxylamine—Pancytopenia—Epirubicin—uterine cancer	0.00192	0.00196	CcSEcCtD
Doxylamine—Hypotension—Etoposide—uterine cancer	0.00192	0.00196	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—uterine cancer	0.00184	0.00187	CcSEcCtD
Doxylamine—Dyspnoea—Etoposide—uterine cancer	0.00183	0.00187	CcSEcCtD
Doxylamine—Somnolence—Etoposide—uterine cancer	0.00183	0.00186	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—uterine cancer	0.00181	0.00184	CcSEcCtD
Doxylamine—Vomiting—Dactinomycin—uterine cancer	0.00181	0.00184	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00179	0.00182	CcSEcCtD
Doxylamine—Rash—Dactinomycin—uterine cancer	0.00179	0.00182	CcSEcCtD
Doxylamine—Decreased appetite—Etoposide—uterine cancer	0.00179	0.00182	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—uterine cancer	0.00178	0.00181	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00178	0.00181	CcSEcCtD
Doxylamine—Fatigue—Etoposide—uterine cancer	0.00177	0.00181	CcSEcCtD
Doxylamine—Constipation—Etoposide—uterine cancer	0.00176	0.00179	CcSEcCtD
Doxylamine—Sweating—Epirubicin—uterine cancer	0.00173	0.00176	CcSEcCtD
Doxylamine—Feeling abnormal—Etoposide—uterine cancer	0.00169	0.00173	CcSEcCtD
Doxylamine—Nausea—Dactinomycin—uterine cancer	0.00169	0.00172	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—uterine cancer	0.00169	0.00172	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—uterine cancer	0.00167	0.0017	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00166	0.00169	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—uterine cancer	0.00165	0.00168	CcSEcCtD
Doxylamine—Urticaria—Etoposide—uterine cancer	0.00163	0.00166	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—uterine cancer	0.00162	0.00165	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—uterine cancer	0.0016	0.00163	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—uterine cancer	0.0016	0.00163	CcSEcCtD
Doxylamine—Urethral disorder—Epirubicin—uterine cancer	0.00159	0.00162	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—uterine cancer	0.00156	0.00159	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—uterine cancer	0.00153	0.00156	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—uterine cancer	0.00153	0.00156	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—uterine cancer	0.00152	0.00154	CcSEcCtD
Doxylamine—Hypersensitivity—Etoposide—uterine cancer	0.00151	0.00154	CcSEcCtD
Doxylamine—Flushing—Epirubicin—uterine cancer	0.00151	0.00153	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—uterine cancer	0.00151	0.00153	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—uterine cancer	0.0015	0.00153	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—uterine cancer	0.00148	0.00151	CcSEcCtD
Doxylamine—Asthenia—Etoposide—uterine cancer	0.00148	0.0015	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—uterine cancer	0.00147	0.0015	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—uterine cancer	0.00147	0.00149	CcSEcCtD
Doxylamine—Mediastinal disorder—Epirubicin—uterine cancer	0.00146	0.00149	CcSEcCtD
Doxylamine—Pruritus—Etoposide—uterine cancer	0.00145	0.00148	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—uterine cancer	0.00142	0.00145	CcSEcCtD
Doxylamine—Erythema—Epirubicin—uterine cancer	0.00141	0.00144	CcSEcCtD
Doxylamine—Diarrhoea—Etoposide—uterine cancer	0.00141	0.00143	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—uterine cancer	0.0014	0.00143	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—uterine cancer	0.00139	0.00142	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—uterine cancer	0.00139	0.00142	CcSEcCtD
Doxylamine—Dizziness—Etoposide—uterine cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—uterine cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—uterine cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—uterine cancer	0.00135	0.00138	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—uterine cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Vomiting—Etoposide—uterine cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—uterine cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Agitation—Epirubicin—uterine cancer	0.0013	0.00132	CcSEcCtD
Doxylamine—Rash—Etoposide—uterine cancer	0.0013	0.00132	CcSEcCtD
Doxylamine—Dermatitis—Etoposide—uterine cancer	0.0013	0.00132	CcSEcCtD
Doxylamine—Malaise—Epirubicin—uterine cancer	0.00127	0.0013	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—uterine cancer	0.00127	0.00129	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—uterine cancer	0.00126	0.00129	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—uterine cancer	0.00126	0.00128	CcSEcCtD
Doxylamine—Palpitations—Epirubicin—uterine cancer	0.00125	0.00127	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—uterine cancer	0.00122	0.00125	CcSEcCtD
Doxylamine—Nausea—Etoposide—uterine cancer	0.00122	0.00124	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—uterine cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—uterine cancer	0.0012	0.00122	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—uterine cancer	0.0012	0.00122	CcSEcCtD
Doxylamine—Discomfort—Epirubicin—uterine cancer	0.00119	0.00121	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—uterine cancer	0.00118	0.0012	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—uterine cancer	0.00118	0.0012	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—uterine cancer	0.00117	0.0012	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—uterine cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—uterine cancer	0.00116	0.00118	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—uterine cancer	0.00115	0.00118	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—uterine cancer	0.00115	0.00117	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—uterine cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—uterine cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—uterine cancer	0.00113	0.00115	CcSEcCtD
Doxylamine—Tachycardia—Epirubicin—uterine cancer	0.00112	0.00115	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—uterine cancer	0.00111	0.00113	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—uterine cancer	0.00111	0.00113	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—uterine cancer	0.0011	0.00112	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—uterine cancer	0.0011	0.00112	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—uterine cancer	0.00109	0.00111	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—uterine cancer	0.00108	0.0011	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—uterine cancer	0.00108	0.0011	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—uterine cancer	0.00107	0.00109	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—uterine cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—uterine cancer	0.00104	0.00106	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—uterine cancer	0.00104	0.00106	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—uterine cancer	0.00104	0.00106	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—uterine cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—uterine cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—uterine cancer	0.00102	0.00104	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—uterine cancer	0.00102	0.00104	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—uterine cancer	0.001	0.00102	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—uterine cancer	0.000996	0.00101	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000995	0.00101	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—uterine cancer	0.000994	0.00101	CcSEcCtD
Doxylamine—Constipation—Epirubicin—uterine cancer	0.000986	0.001	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—uterine cancer	0.000965	0.000982	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—uterine cancer	0.000951	0.000968	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—uterine cancer	0.00095	0.000967	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—uterine cancer	0.000948	0.000965	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—uterine cancer	0.000927	0.000944	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000921	0.000938	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—uterine cancer	0.000919	0.000936	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—uterine cancer	0.000916	0.000932	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—uterine cancer	0.000912	0.000929	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—uterine cancer	0.000879	0.000895	CcSEcCtD
Doxylamine—Hypersensitivity—Epirubicin—uterine cancer	0.000849	0.000865	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—uterine cancer	0.000847	0.000863	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—uterine cancer	0.000827	0.000842	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—uterine cancer	0.000815	0.00083	CcSEcCtD
Doxylamine—Diarrhoea—Epirubicin—uterine cancer	0.000789	0.000803	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—uterine cancer	0.000786	0.0008	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—uterine cancer	0.000765	0.000779	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—uterine cancer	0.000762	0.000776	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—uterine cancer	0.000754	0.000768	CcSEcCtD
Doxylamine—Vomiting—Epirubicin—uterine cancer	0.000733	0.000746	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—uterine cancer	0.00073	0.000743	CcSEcCtD
Doxylamine—Rash—Epirubicin—uterine cancer	0.000727	0.00074	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—uterine cancer	0.000726	0.000739	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—uterine cancer	0.000705	0.000718	CcSEcCtD
Doxylamine—Nausea—Epirubicin—uterine cancer	0.000685	0.000697	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—uterine cancer	0.000678	0.00069	CcSEcCtD
Doxylamine—Rash—Doxorubicin—uterine cancer	0.000672	0.000685	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—uterine cancer	0.000672	0.000684	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—uterine cancer	0.000633	0.000645	CcSEcCtD
